AU4555700A - Bis-sulfonamide with anti-hcmv effect - Google Patents

Bis-sulfonamide with anti-hcmv effect

Info

Publication number
AU4555700A
AU4555700A AU45557/00A AU4555700A AU4555700A AU 4555700 A AU4555700 A AU 4555700A AU 45557/00 A AU45557/00 A AU 45557/00A AU 4555700 A AU4555700 A AU 4555700A AU 4555700 A AU4555700 A AU 4555700A
Authority
AU
Australia
Prior art keywords
sulfonamide
bis
hcmv
effect
hcmv effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45557/00A
Inventor
Wolfgang Bender
Peter Eckenberg
Siegfried Goldmann
Sabine Hallenberger
Michael Harter
Jurgen Dr Reefschlager
Jorg Trappe
Olaf Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU4555700A publication Critical patent/AU4555700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU45557/00A 1999-05-06 2000-04-25 Bis-sulfonamide with anti-hcmv effect Abandoned AU4555700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19920790A DE19920790A1 (en) 1999-05-06 1999-05-06 Bis-sulfonamides with anti-HCMV activity
DE19920790 1999-05-06
PCT/EP2000/003687 WO2000068186A1 (en) 1999-05-06 2000-04-25 Bis-sulfonamide with anti-hcmv effect

Publications (1)

Publication Number Publication Date
AU4555700A true AU4555700A (en) 2000-11-21

Family

ID=7907126

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45557/00A Abandoned AU4555700A (en) 1999-05-06 2000-04-25 Bis-sulfonamide with anti-hcmv effect

Country Status (3)

Country Link
AU (1) AU4555700A (en)
DE (1) DE19920790A1 (en)
WO (1) WO2000068186A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060276464A1 (en) * 2005-05-13 2006-12-07 Wyeth Diarylsulfone sulfonamides and use thereof
DE102006009928A1 (en) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituted arylsulfonamides
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
CN107383009B (en) 2012-06-13 2020-06-09 因塞特控股公司 Substituted tricyclic compounds as FGFR inhibitors
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
CN105263931B (en) 2013-04-19 2019-01-25 因赛特公司 Bicyclic heterocycle as FGFR inhibitor
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
EP3617205B1 (en) 2015-02-20 2021-08-04 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
MA41551A (en) 2015-02-20 2017-12-26 Incyte Corp BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
AR111960A1 (en) 2017-05-26 2019-09-04 Incyte Corp CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION
JP2021523118A (en) 2018-05-04 2021-09-02 インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ FGFR inhibitor salt
US11466004B2 (en) 2018-05-04 2022-10-11 Incyte Corporation Solid forms of an FGFR inhibitor and processes for preparing the same
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
AU2020366006A1 (en) 2019-10-14 2022-04-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
BR112022010664A2 (en) 2019-12-04 2022-08-16 Incyte Corp DERIVATIVES OF A FGFR INHIBITOR
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP2024522189A (en) 2021-06-09 2024-06-11 インサイト・コーポレイション Tricyclic Heterocycles as FGFR Inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1049666B1 (en) * 1998-01-23 2003-06-04 Bayer Aktiengesellschaft Novel naphthyl-substituted and anilide-substituted sulfonamides
DE19802436A1 (en) * 1998-01-23 1999-07-29 Bayer Ag New N-aryl sulfonamides as antiviral agents, particularly against cytomegalovirus, e.g. in patients with acquired immune deficiency syndrome
DE19802437A1 (en) * 1998-01-23 1999-07-29 Bayer Ag Use of N-aminophenyl sulfonamides for treating or preventing viral infections, particularly herpes

Also Published As

Publication number Publication date
DE19920790A1 (en) 2000-11-09
WO2000068186A1 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU4555700A (en) Bis-sulfonamide with anti-hcmv effect
AU4512801A (en) Speculum
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU7098000A (en) Signed group criteria
AU2678800A (en) Modified calycins
AU3891900A (en) Notebook with removable sheets
AU4115400A (en) Short-circuiter
AU3838400A (en) Processor
AU2023701A (en) Sketcher
AU4974700A (en) Fluoroalkenyl nortropanes
AU6945600A (en) Hinge
AU1857701A (en) Benzoxa- and benzthiazoles
AU3988100A (en) Processor
AU7447500A (en) Acylsulfonamide derivatives
AU6157000A (en) Naphthyl-substituted sulfonamides
AU1992900A (en) Docking arrangement
AU1901801A (en) Glucofuranoses
AU5007900A (en) Speculum
AU1915601A (en) Periotome
AU6857200A (en) Parallel rule
AU2197301A (en) Microlamp
AU7293900A (en) Edge sensing arrangement
AU7000800A (en) Mixtures with LiPF6
AU1737601A (en) Collectalbum

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase